Amgen Licenses Stem Cell Growth Factors to ViaCell
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)
Published: 4 Feb-2004
DOI: 10.3833/pdr.v2004.i44.830 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
ViaCell licensed several stem cell growth factors from Amgen, in a deal that provides the world’s largest biotechnology company with the right to commercialize the cellular therapy products that result from the collaboration...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS